Concepedia

Publication | Open Access

GPRC5D-Targeted CAR T Cells for Myeloma

DOIFull Paper Access

367

Citations

16

References

2022

Year

Sham Mailankody, Sean M. Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J. Carstens, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xiuyan Wang,
New England Journal of Medicine

Abstract

The results of this study of a GPRC5D-targeted CAR T-cell therapy (MCARH109) confirm that GPRC5D is an active immunotherapeutic target in multiple myeloma. (Funded by Juno Therapeutics/Bristol Myers Squibb; ClinicalTrials.gov number, NCT04555551.).

References

YearCitations

Page 1